Press release

Luxembourg/Geneva, 7 September 2017

IPF Partners Announces Successful Dry Closing of a New Debt Fund, IPF Fund II

With €75m committed so far from top-tier institutional and private investors at the end of July 2017, IPF Partners is on track to achieve its fundraising target of €150m for its new debt fund, IPF Fund II. The first fund, IPF Fund I, amounted to €105m and was raised in 2013. This demonstrates the increased appetite from investors to look at specialized lending strategies.

IPF Partners’ strategy is to provide low to non-dilutive debt financing to small and mid-sized European healthcare companies and bolster commercial launch of innovative products in the pharma/biotech, medtech and diagnostics markets. The funds raised will allow IPF to foster growth of a new generation of market leading healthcare companies and institutions. Typical deal size ranges from €5-25m over 3-6 years duration.

IPF Partners will start investing from IPF Fund II once it completes the investment period of IPF Fund I in the months to come.